Minimally Invasive Biopsy Technologies Market Segmentation, Industry Analysis By Production, Consumption, Revenue And Growth Rate By 2027

Mar 30, 2021 (Market Insight Reports) —

Growing demand for minimally invasive procedures in biopsy owing to its higher convenience is driving the demand for the market.

The Global Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027. The market is expected to be driven due to a higher proliferation of the minimally invasive surgical procedures in biopsy testing and an extensive rise in the rate of breast and lung cancers globally. Around 66% of the total initial breast biopsies performed in North America are minimally invasive breast biopsies (MIBB).

Get Free Exclusive Sample PDF Copy@ https://www.emergenresearch.com/request-sample/75

Further key findings from the report suggest

• The ambulatory surgery centers have a more convenient outpatient procedure alternative to the hospital-based inpatient systems, maintaining a strong track record of quality care. Ambulatory surgery centers, incorporating all the required and modern MIB technologies, are expected to grow fastest amongst the end-use verticals throughout the forecast period.
• The therapeutic application is further segmented into Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, and Non-oncology Application. Minimally invasive breast biopsy (MIBB) has been highly recommended for the pre breast cancer diagnosis and checkup globally. The MIBB is expected to grow higher during the projected period as the number of breast cancer increases.
• Key players in the market include Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, and Owlstone Medical Ltd., among others.

For the purpose of this report, Emergen Research has segmented into the global Minimally Invasive Biopsy Technologies Market on the basis of Technology, Therapeutic Application, End-Use Verticals, and region:

• Technology Outlook (Revenue: USD Billion; 2017-2027)
  • Liquid Biopsy
  • Optical Biopsy
  • Brush Biopsy
  • Pigmented Lesion Assays
  • Breath Biopsy
  • Brush Biopsy
  • Others
• Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Blood Cancer
  • Non-oncology Applications
• End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Others

Key Geographies Encompassed in the Report:

• North America (U.S., Canada)
• Europe (U.K., Germany, Italy, France, Rest of EU)
• AsiaPacific (India, Japan, China, Australia, Rest of APAC)
• Latin America (Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Make An Inquiry Of This Report @ https://www.emergenresearch.com/purchase-enquiry/75

Additionally, the report analyzes the principal strategies implemented by the companies operating across this industry vertical, such as mergers and acquisitions, collaborations, joint ventures, product launches, and brand promotions, to strengthen their global footprint. The report aims to offer a holistic examination of the industry’s relevant features to the interested readers in a bid to help them leverage future growth prospects.

Key questions addressed in the report:

• Which factors could potentially hamper the global market growth during the forecast period?
• How is the raw material availability affecting the demand for Minimally Invasive Biopsy Technologies in this industry vertical?
• Which regional market offers the most attractive growth opportunities to the companies operating in this market?
• Who are the leading players dominating the global Minimally Invasive Biopsy Technologies Market?

Table of Content

Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Minimally Invasive Biopsy Technologies Market Segmentation & Impact Analysis
4.1. Minimally Invasive Biopsy Technologies Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing proliferation of the minimally invasive surgical procedure
4.2.2.2. Extensive rise in the cancers & biopsy testing
4.2.2.3. Minimum hospitalization for biopsy testing
4.2.3. Market restraints analysis
4.2.3.1. Unavailability of the skilled professional
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis

Chapter 5. Minimally Invasive Biopsy Technologies Market By Technology Insights & Trends, Revenue (USD Billion)
5.1. Technology Dynamics & Market Share, 2019 & 2027
5.1.1. Liquid Biopsy
5.1.2. Optical Biopsy
5.1.3. Brush Biopsy
5.1.4. Pigmented Lesion Assays
5.1.5. Breath Biopsy
5.1.6. Brush Biopsy
5.1.7. Others

Chapter 6. Minimally Invasive Biopsy Technologies Market By Therapeutic Application Insights & Trends Revenue (USD Billion)
6.1. Therapeutic Application Dynamics & Market Share, 2019 & 2027
6.1.1. Lung Cancer
6.1.2. Breast Cancer
6.1.3. Prostate Cancer
6.1.4. Colorectal Cancer
6.1.5. Blood Cancer
6.1.6. Non-oncology Applications

READ MORE…!

For more Information or Any Query Visit: https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market

Thank you for reading our report. For further queries regarding the report, please get in touch with us. Our team will ensure your report is customized as per your requirements.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs